Stay updated with breaking news from Digital Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than 150 industry figures attended a major, flagship event at Lancaster University, shining a spotlight on the critical role of cyber security leadership.Held on Thursday and Friday July 6th and 7th, the two-day Cyber Security Leadership Symposi
The ongoing development of new-generation distribution and transmission networks is expected to favor the industry growth in the coming time.
13 1Refers to continuing operations as defined on page 43 of the Condensed Financial Report, excludes Alcon, includes the businesses of Innovative Medicines and Sandoz, as well as the continuing corporate functions. 2Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 55 of the Condensed Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 3 Please see detailed guidance assumptions on page 8 including the forecast assumption ...
Novartis International AG: Novartis delivered sales growth and margin expansion. Continued to progress its next wave of medicines in 2020. Pharmaceuticals BU grew 5% (cc) driven by Entresto (+44% cc), Cosentyx (+13% cc), Xiidra acquisition (+95% cc) Promacta/Revolade (+23% cc), Piqray (reaching USD 0.3 billion) Sandoz sales were in line (cc, -1% USD), with Biopharmaceuticals growing 19% (cc) COVID-19 negatively impacted demand, particularly: ophthalmology, dermatology and Sandoz retail Core operating income² grew 13% (cc, +9% USD) and Innovative Medicines and Sandoz core margin improved...